Peer review reports
From: Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial
Original Submission |
14 Feb 2024 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
8 Mar 2024 |
Author responded |
Author comments - Graham McIlroy
|
Resubmission - Version 3 |
8 Mar 2024 |
Submitted |
Manuscript version 3
|
Publishing |
12 Mar 2024 |
Editorially accepted |
|
25 Mar 2024 |
Article published |
10.1186/s12885-024-12112-0
|
Learn about peer review